Ditchcarbon
  • Contact
  1. Organizations
  2. American Oriental Bioengineering, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated 24 days ago

American Oriental Bioengineering, Inc.

Company website

American Oriental Bioengineering, Inc., often referred to as AOB, is a prominent player in the biotechnology and pharmaceutical industry, headquartered in China. Founded in 1998, the company has established a strong presence in the development and manufacturing of herbal extracts, dietary supplements, and bio-pharmaceutical products, catering to both domestic and international markets. With a focus on innovative solutions, AOB's core offerings include high-quality herbal extracts and advanced bioengineering products that stand out for their purity and efficacy. The company has achieved significant milestones, including strategic partnerships and expansions that have solidified its market position. Recognised for its commitment to research and development, American Oriental Bioengineering continues to lead in the integration of traditional herbal medicine with modern scientific practices, making it a trusted name in the health and wellness sector.

DitchCarbon Score

How does American Oriental Bioengineering, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

22

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

American Oriental Bioengineering, Inc.'s score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.

22%

Let us know if this data was useful to you

American Oriental Bioengineering, Inc.'s reported carbon emissions

American Oriental Bioengineering, Inc., headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in the latest available records. Consequently, there are no documented Scope 1, 2, or 3 emissions to analyse. Furthermore, the company has not established any formal reduction targets or commitments, including those aligned with the Science Based Targets initiative (SBTi). This lack of defined climate pledges suggests that American Oriental Bioengineering, Inc. may not yet be actively engaged in formal climate action initiatives. In the context of the industry, many companies are increasingly adopting sustainability measures and setting ambitious targets to reduce their carbon footprints. However, without specific data or commitments from American Oriental Bioengineering, Inc., it remains unclear how the company plans to address climate change or contribute to global emissions reduction efforts.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. American Oriental Bioengineering, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for American Oriental Bioengineering, Inc. is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

American Oriental Bioengineering, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated 9 minutes ago

Guangxi Zhuangzu Autonomous Region Huahong Pharmaceutical Co., Ltd.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Rong Yu Pharmaceuticals Limited

CN
•
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

Sino Biopharmaceutical

HK
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Hua Medicine

CN
•
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy